Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation.

[1]  C. Perry,et al.  Cyclosporin , 2012, Drugs.

[2]  C. Magee,et al.  The growing problem of chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.

[3]  R. Wolfe,et al.  Chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.

[4]  O. Pankewycz,et al.  Basiliximab plus low‐dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation , 2003, Clinical transplantation.

[5]  R. Hershberger,et al.  Pre-operative renal function predicts development of chronic renal insufficiency after orthotopic heart transplantation. , 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  D. Mancini,et al.  Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. , 2000, The New England journal of medicine.

[7]  G. Brandenberger,et al.  Circulating adrenomedullin is increased after heart transplantation. , 1999, Cardiovascular research.

[8]  R. Zietse,et al.  Renal insufficiency after heart transplantation: a case-control study. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  J. Soulillou,et al.  Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients , 1997, The Lancet.

[10]  R. Woolfson,et al.  Cyclosporin nephrotoxicity following cardiac transplantation. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  Perazella Ma,et al.  Acute renal failure after cardiac transplantation: a case report and review of the literature. , 1996 .

[12]  B. Ganzel,et al.  Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[13]  W. S. Ring,et al.  Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation. , 1990, Circulation.

[14]  B. Jaffe,et al.  In vivo potentiation of cyclosporine immunosuppression by calcium antagonists. , 1987, Transplantation proceedings.

[15]  B. Myers,et al.  Cyclosporine-associated chronic nephropathy. , 1984, The New England journal of medicine.

[16]  T C Chalmers,et al.  Randomized versus historical controls for clinical trials. , 1982, The American journal of medicine.